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1. Introduction
The increasing burden being placed on health care services by 
an aging population, obesity epidemic and diabetes epidemic 
[1] is creating a necessity for point-of-care testing for serious 
pathologies such as cardiovascular disease and diabetes [2]. 
New developments in economical analytical screening tools 
such as lab-on-a-chip [3], lab-on-a-disc [4] and microfluidic 
analysis systems [5] focus on miniaturisation and dispos-
ability to improve performance, speed, and portability.
The advance of solid freeform fabrication techniques, such 
as 3D-printing, has significantly improved the ability to pre-
pare solid structures with precise geometries [6], including 
internal cavities, facilitating the rapid production of analytical 
platforms and the ability to alter or redesign any aspect without 
significantly inflating costs. The rapid advancement of low-
end 3D printing technology is due largely to the development 
of free and open source software and hardware development 
[7]. In addition, there is a large library of freely available CAD 
models, which provides shortcuts to product development.
The ability to manufacture detailed and complex  prototypes 
in a fast and efficient way has caused rapid prototyping 
technology to become a fundamental tool for many areas 
of research and development. Fused deposition modelling 
(FDM) based 3D printers are readily available for purchase 
either as self-assembly kits or as pre-assembled units. While 
the use of 3D-printing to produce cost-effective tools for bio-
medical applications has significant potential [8, 9], to date its 
use in the optical and biosensors ﬁeld is limited.
Traditionally, glass and silicon have been used in the fab-
rication of microfluidic devices due to their well-established 
properties and manufacturing techniques, such as photoli-
thography and micromachining [10]. However, more recently, 
the use of relatively inexpensive large scale techniques such 
as injection molding and hot embossing has led to an increase 
in the use of polymers for economical microfluidic device 
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manufacturing [11]. As well as being low-cost and disposable, 
polymers are highly adaptable for diagnostic purposes [12]. 
This has resulted in materials such as polymethylmethacrylate 
(PMMA) and polydimethylsiloxane (PDMS) becoming highly 
desirable for microfluidic device prototyping [10], and for the 
manufacture of disposable lab equipment such as the PMMA 
cuvettes used in this work. While polylactic acid (PLA) is not 
yet commonly used as a microfluidic platform, devices have 
been developed [13], and PLA’s biochemical properties and 
suitability for surface chemistry are understood [14, 15].
3D-printed optical assay platforms can suffer from the poor 
optical characteristics [16] of the available polymers such as 
PLA and acrylonitrile butadiene styrene (ABS), par ticularly 
their poor optical transparency, which is a fundamental 
obstacle that must be overcome for the technology to pro-
gress. In addition, FDM suffers from a large inhomogeneity 
between the layers and strands of plastic, which causes the 
formation of air pockets between strands. The distribution of 
small air pockets throughout the model causes scattering and 
attenuation of transmitted light. Other 3D printing techniques 
such as stereolithography and inkjet printing have higher reso-
lution, which greatly reduces the formation of these gaps.
Chen et al used FDM of a proprietary acrylate-based polymer 
material, Vero Clear, to produce plates for use with a standard 
plate reader for the quantitative analysis of red blood cells for 
transfusion medicine. Whilst capable of printing the plates, the 
Objet Connex 350 Multi-material 3D printer that was used to 
print the devices costs over $200 000 and the devices required 
post-print finishing including cleaning and polishing using 
sand paper and water to achieve acceptable physical properties 
and the levels of optical transparency required for use with a 
standard plate reader [17]; these finishing techniques would be 
unsuitable for use in sealed microfluidic channels. In addition, 
the material used is not readily available for public use.
Dolomite FDM printers have been able to produce reliable 
channels of dimensions down to 300 µm using PLA plastic 
[18]. While the Dolomite printers are an order of magnitude 
cheaper than the most expansive printers, they currently cost 
~£13 000 for the printer and ~£350 for the materials, which 
is still expensive when compared to consumer grade FDM 
printer prices (~£1000 and £15).
Erkal et al also used an Objet Connex 350 Multi-material 
3D printer to produce 0.5 mm2 microfluidic channels for use 
with electrodes for the detection of dopamine. Post-print tech-
niques including sonication and scraping were required to 
properly form channels of the desired specification [19].
The requirement for post-print finishing techniques such 
as the physical removal of material and polishing to improve 
3D-printed objects limits greatly the potential for the 3D 
printing of optical microfluidic devices, especially for the 
fabrication of inaccessible microfluidic channels. This empha-
sises the need for the development of accessible and affordable 
prototyping technology.
Here we demonstrate a low cost disposable microfluidic 
optical device designed and manufactured using single step 
3D-printing technology; the device is based on a cuvette, with 
a path length of 500 µm and a capacity of 50 µl. Optimisation 
of the optical transparency of the 3D-printed plastic was also 
investigated using various techniques during and after manu-
facture. The device was used to perform an enzymatic cascade 
reaction for the optical quantification of glucose.
While numerous analytical procedures involving chemical 
and enzymatic techniques have been used within glucose 
assays, enzymatic methods have been the most popular 
due to their increased specificity and selectivity. Enzymatic 
methods use glucose oxidase (GlOx) to oxidize glucose to 
produce D-gluconic acid and hydrogen peroxide (H2O2); the 
H2O2 is then quantified. Wong et  al discovered that horse-
radish peroxidase (HRP) catalyses the oxidative coupling of 
chromotropic acid (CTA) and aminoantipyrine (AAP) with 
hydrogen peroxide to produce a blue quinoneimine dye with 
high absorbance in a spectral region centred on 590 nm [20].
In this work, a glucose assay utilizing an enzymatic cas-
cade of glucose oxidase, HRP, CTA and 4-AAP was used for 
the production of a blue quinoneimine dye. 
− + + − +D Glucose H O O D Gluconic Acid H O2 2
G1Ox
2 2  ⎯ →⎯⎯⎯⎯    
     
    ⎯ →⎯⎯⎯  
+ −
+ +
Chromotropic acid 4 aminoantipyrine
2H O quinoneminie dye 4H O.2 2
HRP
2
The absorbance could be measured and compared against a 
calibration curve giving an accurate concentration of glucose 
in solution. The method involves a single aqueous reagent, 
requires no sample pre-treatment, is reproducible, simple, 
specific, and uses no corrosive reagents.
The platform has been designed and manufactured using 
standard, readily available 3D-printing software and hard-
ware, capable of providing results in less than 5 min, which 
can be read using spectrometers and photometric equipment.
2. Methods
Phosphate buffered saline (PBS, 10 mM phosphate buffer, 
2.7 mM potassium chloride and 137 mM sodium chloride, 
pH 7.4) tablets, CTA disodium salt dihydrate (CTA), 4-AAP, 
isopropyl alcohol, HRP Type II essentially salt-free, lyophi-
lized powder, 150–250 units mg−1 solid (using pyrogallol) 
(HRP), D-glucose, glucose oxidase from Aspergillus niger 
lyophilized, powder, and ~200 units mg−1 protein (GlOx), 
were purchased from Sigma-Aldrich (Poole, UK). Ultrapure 
water (18 MΩ cm−1) was produced using a Milli-Q water 
system (Millipore Corp., Tokyo, Japan). The concentration of 
glucose in samples was tested and quantified independently 
using an Optium Exceed Blood Glucose Monitoring System 
(Abbott, UK).
2.1. Glucose assay optimisation
The glucose assay consists of using an enzymatic cascade to 
produce a blue dye with an absorbance correlating to glucose 
concentration. The reagents which combine to produce the 
dye are CTA and 4-AAP. According to the reaction proposed 
by Wong et al, H2O2 reacts with CTA and AAP in the presence 
of HRP [20] with a molar ratio of CTA:AAP for maximum 
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colour produced being 5:1. It is necessary that the concentra-
tions of CTA and AAP are sufficient to quantify accurately 
the substrate within the required detection range (0–10 mM). 
It was determined that a concentration ratio of 2:1 CTA:AAP 
was required for a substrate detection range of 0–10 mM 
glucose. 
It should be noted, that although a 1:1 CTA:AAP ratio 
should be sufficient, the concentration of CTA must be in 
excess of that of AAP to prevent AAP dimerization. In the 
CTA/AAP reaction, CTA is oxidised by HRP producing CTA 
radicals. The CTA radicals then react with AAP to produce 
AAP radicals and CTA. The AAP radicals then react with 
CTA radicals in solution and H2O2 to produce blue quinon-
eimine dye. By increasing the AAP in the reagent mixture, 
the probability of direct oxidation of AAP by oxidised HRP 
is increased, which then increases the concentration of aminyl 
radicals and subsequently the probability of their dimerization 
[21]. The result of this is a decreased concentration of blue 
quinoneimine dye and an increased concentration of AAP 
dimers. By maintaining a high concentration of CTA with 
respect to AAP, the blue dye reaction pathway is enhanced.
Glucose assay reagent solution was made by dissolving 
CTA, 4-AAP, glucose oxidase (0–50 units ml−1) and HRP 
(0–10 units ml−1) in the PBS solution. The reaction was started 
by adding the glucose solution (up to a final  concentration 
range of 0–10 mM). The assay was read after 2 min incubation 
and the absorption spectrum recorded.
Serial dilution matrices were performed for CTA 
(0–80 mM) and 4-AAP (0–80 mM) using 6 U ml−1 HRP and 
10 U ml−1 glucose oxidase (GlOx). The reaction was started 
by adding 0–10 mM glucose solution. Concentration curves 
were produced (see the supplementary data) to determine the 
optimum concentration values for enzyme and reagents.
Glucose oxidase and HRP concentrations were determined 
using a fixed time method as this is more applicable in most 
clinical assays. Serial dilutions were performed of GlOx 
(0–50 U ml−1) and HRP (0–10 U ml−1) using CTA 20 mM and 
AAP 10 mM. The reactions were started by adding a 10mM 
glucose solution. The assay was incubated for 2 min and the 
absorbance was then measured. Samples were allowed to incu-
bate for a further 3 min and the absorbance was measured again.
A Varioskan Flash spectral scanning multimode reader 
(ThermoScientific LTD, UK) was used in conjunction with 
the PC software package SkanIt to determine the absorbance 
values of the assays. Assay optimisation was carried out in 
Nunc-Immuno MaxiSorp flat bottom 96 well plates (Sigma-
Aldrich, UK).
2.2. Fabrication of 3D-printed microfluidic device  
and 3D printed samples
The primary stages involved in making a 3D printed product 
are the creation of a CAD file, conversion and preparation of 
the file using a slicer program, uploading the file to the printer 
and finally the physical creation of the object. All 3D printed 
models were fabricated using an Ultimaker 2  +  3D printer 
using a 0.4 mm nozzle size. The accuracy of the printer in the 
X, Y and Z dimensions is 12.5, 12.5 and 5 µm respectively. The 
nozzle size of 0.4 mm limits the positioning of features close 
to each other but still allows for the design and construction 
of features (such as channels) of dimensions down to approxi-
mately 20 µm. However, while it is possible to create channels 
with this resolution, currently their formation is not reliable, 
and working at this scale would require improvements to the 
consistency of the plastic extrusion.
A number of different batches and makes of transparent 
filaments were used. The filaments tested include: Ultimaker 
PLA Translucent, Ultimaker PLA Transparent, Innofil PLA 
Natural and InnoPET Natural.
For this work, two different 3D models were designed. 
The first was a square of Ultimaker PLA Translucent plastic 
20 mm2 with 400 µm thickness and path length. The second 
was a 12  ×  12  ×  42 mm cuvette which has an internal micro-
fluidic cavity with a thickness of 500 µm, this design is shown 
in figure 1. The circular tube to one side is included to allow 
for the total filling of the cavity. Multiple cuvettes were made 
from the variety of plastic filaments mentioned previously.
When printed, the measured thickness of the cavity was 
480 µm. This was measured using an Olympus light micro-
scope (model) in three locations along the length of the cavity. 
The measurement had an error of  ±10 µm.
Figure 1. Schematic of the microfluidic device [22]. Figure 2. Attenuation at 633 nm in 400 µm thick plastic samples 
of ultimaker PLA translucent made with six different layer heights, 
n  =  3, error bars are the standard deviation of the repeats [23].
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Both models were designed using the 3D-modelling CAD 
software Sketchup 2015 Pro (Trimble Navigation Ltd, USA). 
The device file was converted to an STL file and processed 
using the slicer program Cura (Ultimaker Ltd, Netherlands). 
Cura was also used to calibrate and optimise the print param-
eters by adjusting layer height and print speed.
2.3. Glucose assay in 3D-printed microfluidic device
Glucose assay reagent solution was made by dissolving CTA 
(up to a final concentration of 20 mM), 4-AAP (up to a final 
concentration of 10 mM), glucose oxidase (20 units ml−1) 
and HRP (6 units ml−1) in a PBS solution. The reaction was 
started by adding glucose solution (up to a final concentration 
of 0–10 mM). The assay was read after a 2 min incubation and 
the absorption spectrum recorded. The assay was performed 
in a microfluidic device and the absorbance spectra assessed 
using the equipment described in section 2.5.
2.4. Instrumentation used to measure attenuation
Instrumentation was assembled to quantify the optical attenu-
ation of the 3D-printed plastic samples. Plastic samples were 
mounted at a fixed distance in front of a Newport 1825-C 
Optical Power Meter (Newport, USA). The sample was 
then illuminated with a helium–neon laser (Uniphase, UK), 
operating at 633 nm and with an output power of 0.8 mW and 
fitted with a beam expander to create a beam waist of 20 mm. 
The attenuation of the sample was recorded as the difference 
between the transmitted power with and without the sample 
under test.
2.5. Spectral analysis instrumentation
The absorbance of the substrate assay reaction in the 
3D-printed microfluidic devices was quantified by ana-
lysing the transmission spectrum of the assay using a fibre 
coupled tungsten halogen light source (Ocean Optics ecoVis, 
Ocean Optics, USA) and a CCD spectrometer Ocean Optics 
ADC1000-USB spectrometer (Ocean Optics, USA). The light 
source has an integrated cuvette holder which was adapted to 
hold the microfluidic devices. The light source and the spec-
trophotometer were connected using a short length (10 cm) of 
multimode optical fibre.
3. Results and discussion
The investigation of the use of 3D printed plastics for micro-
fluidic devices had two key aims. Firstly, the optimisation of 
the 3D printing methodology to produce plastic samples 
of sufficient optical quality to allow the optical interrogation 
of internal cavities. Secondly, the demonstration of filling and 
reading a biological assay within a 3D printed microfluidic 
device.
Optimisation of the 3D printing methodology focussed 
on both the printing layer height and the speed of the plastic 
deposition. Once optimised the device repeatability was also 
demonstrated.
Prior to running a colorimetric glucose assay the microflu-
idic device, an optimisation process was undertaken to first 
develop a reliable glucose assay protocol and then produce a 
dilution curve by running the assay in a commercial well plate 
which was subsequently read with a commercial plate reader 
system.
3.1. The effect of print speed and layer height on optical 
transparency
As previously discussed, many factors can influence a 
3D-printed object; it can take several print attempts and 
varying conditions to produce an object with the desired 
properties. The FDM printer used here deposits layers of 
polymer on top of each other to build up the object. The 
influence of these layers’ height on the attenuation of 
the transmitted light was investigated by characterising 
3D-printed solid plastic samples as described in 2.4. These 
samples were fabricated at 10 mm s−1 with varying layer 
heights of the plastic. The total thickness of the object was 
unchanged; only the height of the layers (and therefore the 
number of layers) was altered.
Figure 3. Attenuation in Ultimaker PLA translucent plastic samples 
made with three different layer heights at three different speeds, 
n  =  3, error bars are the standard deviation of the repeats [24].
Figure 4. Difference as a percentage of intensity in the spectra of 
3D printed cuvette devices compared to a PMMA cuvette [25].
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As demonstrated in figure 2, an increase in the layer height 
increases the attenuation of the transmitted light. However, 
at 0.04 and 0.06 mm layer heights the difference between the 
attenuation measurements was less than the experimental error.
As layers are deposited, air can be trapped between the layers, 
reducing homogeneity. Such air pockets and the corresponding 
reduction in the merging of the polymer layers is thought to 
be responsible for the clouding observed in the printed sam-
ples and the measured reduction in optical transparency. Where 
homogeneity between layers was improved, it was observed 
by eye that the optical transparency increased, even if intermit-
tently and not through the entire object. It could expected that 
increasing layer height would increase the optical transparency, 
as there are fewer layers and therefore less potential for air 
gaps, however it is proposed that as the layer height increases 
the circular nature of the FDM extruded plastic, causing the air 
pockets to become larger, decreasing optical transparency.
A proposed solution to the formation of air gaps was to vary 
the print speed to allow the plastic time to flow into the gaps. 
However, as shown in figure 3, the variation of the print speed 
had a mixed impact on the attenuation caused by the Ultimaker 
PLA Translucent plastic samples. For 0.06 mm layer height, the 
increased speeds appeared to reduce the attenuation slightly. 
Whereas layer heights of 0.15 and 0.25 mm showed a slight 
increase in attenuation with speed. In all cases the change is 
small and is less than 10% of the overall attenuation. 
Further experiments at a wider range of speeds were attempted 
but this increased the failure rate of the prints. It has been docu-
mented that at higher print speeds the chance of print failure 
increases. This is due to the increased risk of the print not sticking 
to the bed, overheating, layer shifting and misalignment, grinding 
of the filament leading to interruption of the feed, and increased 
vibrations impacting the quality of fine details. This results in 
either incomplete, inadequate quality or aborted prints.
3.2. Device variability
To investigate the repeatability of the optical properties of the 
3D printed devices, microfluidic devices were manufactured 
from a selection of transparent PLA filaments as described in 
section 2.2. Three devices were produced from each filament so 
that the inter and intra-filament variability could be observed. 
The difference in the spectra of multiple devices (n  =  3) made 
from the same filament were compared using the equipment 
described in section 2.5 and the resulting average spectra are 
presented in figure 4. Each device was read a total of five times. 
In this data the spectra of a PMMA cuvette was used as the 
reference in order to highlight the spectral differences between 
the commercial PMMA material and the 3D printed samples.
The spectra shown all have a similar form. All of the plastic 
filaments show around a 15% increase in the 390 to 700 nm 
region and around a 10% decrease in from 700 to 1000 nm. 
The Innofil Natural and Ultimaker Translucent plastics have 
less absorbance in the 390 to 700 nm range and appear to have 
decreased absorbance in the 700 to 1000 nm range.
At the 590 nm absorbance peak of the quinoneimine dye 
the inter-filament coefficient of variance (CV) was less than 
1% and there was a maximum CV of 2.6% between 390–
700 nm. The intra-filament CVs are shown in table 1, where 
the transmission spectrum of each device was recorded a total 
of five times and averaged.
For a device to be used as an assay platform, reproducibility 
is imperative; any optical differences between 3D-printed 
devices could have an impact on the quantified data leading to 
inaccurate conclusions. While the spectral data showed good 
reproducibility between absorbance profiles of devices made 
from the same filament batch, the large differences observed 
between filament batches require that a filament specific cali-
bration curve is used for each batch of filament to maximise 
the accuracy of quantitative data produced in each device.
Using an optical coherence tomography (OCT) instrument 
(Spectral Radar OCT, Thorlabs, Germany), the characteristics 
of three channels of depth 400 µm and width 1000 µm were 
Figure 5. Microfluidic cuvette before (a) and after (b) 
quinoneimine dye reaction. Also shown are a microfluidic cuvette 
prepared with a 100 µm thick chamber (c) and an S-shaped  
channel (d).
Figure 6. Change in the absorbance spectra with glucose 
concentration [27].
Table 1. Summary table showing intra filament % coefficient of 
variance (CV).
Filament type CV between devices (n  =  3) (%)
Ultimaker translucent 4
Ultimaker transparent 7
Innofil 4
InnoPET 3
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investigated. OCT is a low coherence interferometry technique 
that can be used to measure the optical thickness of layers within 
semi-transparent materials with a resolution on the micron 
scale [26]. From the OCT images it was possible to assess 
the surface roughness of the internal channels. Each channel 
was assessed at four locations, revealing a surface roughness 
of 135 µm with an average standard deviation of 53 µm. It is 
thought that one of the largest contributing factors in the rough-
ness is the nozzle size of the plastic extruder (in this case 400 
µm). The features most predominant in the OCT images were 
400 µm wide plastic strands sitting slightly above the line of 
the adjacent strands. Future work will explore the improve-
ment of surface roughness using smaller nozzles, of diameter 
down to 125 µm, which are also supported by the Ultimaker 
FDM printer.
3.3. Glucose assay optimisation
Optimisation experiments for the glucose assay were per-
formed in 96 well plates using the chemical and enzyme 
concentrations and equipment described in section 2.1.
Glucose oxidase and HRP concentrations were deter-
mined using a fixed time method as this is more applicable in 
most clinical assays. In all cases, blue quinoneimine dye was 
produced and visible immediately with the colour intensity 
increasing as GlOx or HRP concentration increased. In the 
absence of GlOx or HRP no blue dye was produced. As 1 U 
corresponds to the amount of enzyme which oxidizes 1 µmol 
D-glucose to D-gluconolactone and H2O2 per minute at pH 
7.0 and 25 °C, 20 U ml−1 GlOx should ensure a fast reaction 
rate (⩽2 min) with tolerances for pH and temperature fluctua-
tions [26]. It was determined that enzyme concentrations of 
GlOx 20 U ml−1 and HRP 6 U ml−1 would be sufficient for an 
assay capable of quantifying accurately a biologically relevant 
glucose range of 0–10 mM with a reaction time of 2 min (data 
not shown). Reaction rates can be increased by increasing 
enzyme concentrations accordingly.
3.4. Glucose assay performed in 3D-printed microfluidic 
device
The microfluidic devices manufactured for use with the glu-
cose assay were printed at a rate of 10 mm s−1 with a layer 
height of 0.06 mm using Ultimaker Translucent. The glucose 
assay was performed in the 3D-printed device as described in 
section 2.3. Samples were prepared using the chemical and 
enzyme concentrations described in section 2.2. The reaction 
was started by adding glucose solution of the desired concen-
tration. Figure 5 shows a photograph the microfluidic channel 
before and after the quinoneimine dye reaction. Additionally, 
figure  5 shows a microfluidic cuvette manufactured with a 
100 µm thick fluid cavity and a cuvette with a 500 µm thick 
S-shaped channel. These are included to show the range of 
designs possible using of 3D printing.
The absorbance spectra of the 500 µm thick single chamber 
microfluidic (figure 5(b)) cuvette were recorded using the 
methodology described in section 2.5. The resulting spectra 
are shown in figure 6.
As the glucose concentration increases, the quinoneimine 
dye concentration also increases, resulting in an increase in 
absorbance centred around 590 nm. The spectra produced 
illustrate the range over which absorbance can be quantified, 
providing flexibility in the wavelength, which may be used for 
quantitative purposes. In this work, the absorbance of quino-
neimine dye was quantified at 590 nm. The approximate peak 
absorbance of the quinoneimine dye, for the full range of glu-
cose concentrations are shown in figure 7, alongside the data 
from previous plate reader based experiments.
The data shown in figure 7 demonstrates that it is possible 
to measure glucose concentration using a colourimetric assay 
in a 3D-printed PLA device. The data produced shows a linear 
dilution curve for increasing glucose concentrations with an 
R-squared of 0.99. When compared to results produced with 
a commercial plate reader assay, the 3D-printed microfluidic 
device performs well. There is around a 20–30% difference in 
attenuation, which is consistent with the native attenuation of 
Figure 7. Absorbance at 590 nm comparison between 3D printed microfluidic and well plate reader. Error bars on all points represent three 
standard deviation of three repeats [28].
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the 3D-printed plastic, which reduces the sensitivity as shown 
in figure 3. The limits of detection of the well plate and the 
printed microfluidic devices were determined to be 0.12 and 
0.03 mM, respectively. The lower limit of detection for the 3D 
printed microfluidics is due to the lower error between reps 
compared to the well plate.
4. Conclusions
A colorimetric glucose assay capable of distinguishing 
between a range of glucose concentrations (0–10 mM) in PBS 
pH 7.4 solution has been used to demonstrate the capability 
and functionality of the printed devices. The glucose assay 
was performed in a 3D-printed microfluidic device and absor-
bance data was gathered during testing that shows that it is 
possible to quantify colorimetric assay data in a 3D-printed 
device. The use of an enzymatic cascade demonstrates how a 
multistage assay process can be performed within the device 
as a single user step.
It has previously been thought that the poor optical trans-
parency of 3D–printed polymers is a fundamental obstacle that 
considerably limits their potential to fabricate optically inter-
rogated devices [16]. Furthermore, the variability and error in 
low cost FDM printers was thought to limit their use in fabri-
cating microfluidic structures. When acetone vapour treatment 
[29] was used, it was possible to improve the transparency 
of plastic samples by a further 30%. While not applicable to 
microfluidics this highlights that for some applications it is 
possible to further improve the sensitivity and surface quality 
of devices manufactured using cheap 3D-printers with simple 
post-processing techniques.
Additionally, more expensive 3D-printing techniques have 
higher resolution and better accuracy, which can also improve 
the optical properties of the plastic. However, these systems 
can cost as much as $200 000, which is beyond the budget of 
many research laboratories and would make the cost of indi-
vidual sample holders prohibitive in many applications.
The microfluidic device demonstrated in this paper was 
manufactured using an Ultimaker 2  +  FDM printer costing 
$2000, using filament purchased from the Ultimaker web-
site for $30–$50 per 750 gram reel. Each device cost 3–10¢ 
depending on the filament used, when compared to purchasing 
standard disposable PMMA cuvettes which cost approxi-
mately 7¢ each, resulting in an economical device that can be 
custom designed and built to the users’ requirements without 
having to wait for purchasing or delivery. Further investigation 
is to be performed into secondary adsorption phenomena that 
may influence the analytical spectroscopy and reproducibility 
of data involving 3D-printed PLA devices however the use 
of PLA in biochemical devices is already established [14,15].
Whilst many industrial microfluidic devices are produced 
using injection molding, this is a very costly production 
method for research labs [30] as each design change can 
cost as much as $3000 to have the molds made. The use of 
3D-printing in device fabrication would allow researchers to 
prototype various microfluidic systems quickly and cheaply, 
both reducing the cost and time for development of a micro-
fluidic platform. 3D printing also allows for structures and 
shapes that are not possible in injection molding and could 
open up new 3D designs in microfluidics. This includes the 
inclusion of electrodes and other devices into the 3D printed 
structure. This is something we have already begun exploring 
with simple electrode systems and fibre optic sensors.
In future work we will look at complex microfluidic struc-
tures as well as the flow dynamics of 3D-printed surfaces. It 
is also envisaged that this will expand into testing the suita-
bility of this approach for blood and urine analysis and further 
develop in to complex 3D-printed devices such as lab-on-a-
disc assay platforms providing mobile diagnostic information 
efficiently and cheaply for personal health monitoring.
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